Showing results (291-300 of 302) with videos related to
Sort By:
Pageof 31
NPJ Genomic Medicine|June 30, 2026
Landscape of copy number variants in Spanish people with dementiaItziar de Rojas, Pablo García-González, Clàudia Olivé, et al.Molecular Psychiatry|March 23, 2019
The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's diseaseNicolai Franzmeier, Jinyi Ren, Alexander Damm, et al.Nature Reviews. Immunology|December 9, 2024
Neuroinflammation in Alzheimer diseaseMichael T Heneka, Wiesje M van der Flier, Frank Jessen, et al.Nature Medicine|June 18, 2024
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALSMadhurima Chatterjee, Selcuk Özdemir, Christian Fritz, et al.Acta Neuropathologica|June 6, 2014
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degenerationJulie van der Zee, Tim Van Langenhove, Gabor G Kovacs, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkersNiklas Mattsson, Ulf Andreasson, Staffan Persson, et al.Human Mutation|December 24, 2016
TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral SclerosisJulie van der Zee, Ilse Gijselinck, Sara Van Mossevelde, et al.Neuron|November 3, 2022
Microglia states and nomenclature: A field at its crossroadsRosa C Paolicelli, Amanda Sierra, Beth Stevens, et al.Acta Neuropathologica|September 6, 2022
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkersIris E Jansen, Sven J van der Lee, Duber Gomez-Fonseca, et al.JAMA Neurology|January 31, 2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J Jansen, Olin Janssen, Betty M Tijms, et al.Pageof 31